CD44 and Miyoshi myopathy: Since syndecan-1 is the dominant, if not the only, heparan sulfate proteoglycan expressed on MM cells, the data would indicate that these antibodies also target the heparan sulfate on the syndecan-1 protein (Supplementary Figure S1).